Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Sanofi

02 2Octapharma

03 20Swedish Orphan Biovitrum AB

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Schedule D

Registration Country : Canada

RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN

Brand Name : ALPROLIX

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 500UNIT/VIAL

Packaging :

Approval Date :

Application Number : 2422913

Regulatory Info : Schedule D

Registration Country : Canada

Sanofi Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Schedule D

Registration Country : Canada

RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN

Brand Name : ALPROLIX

Dosage Form : KIT

Dosage Strength : 1000UNIT/VIAL

Packaging :

Approval Date :

Application Number : 2422921

Regulatory Info : Schedule D

Registration Country : Canada

Sanofi Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Schedule D

Registration Country : Canada

RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN

Brand Name : ALPROLIX

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 2000UNIT/VIAL

Packaging :

Approval Date :

Application Number : 2422948

Regulatory Info : Schedule D

Registration Country : Canada

Sanofi Company Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Schedule D

Registration Country : Canada

RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN

Brand Name : ALPROLIX

Dosage Form : KIT

Dosage Strength : 3000UNIT/VIAL

Packaging :

Approval Date :

Application Number : 2422956

Regulatory Info : Schedule D

Registration Country : Canada

Sanofi Company Banner

05

BePharma
Not Confirmed
arrow
arrow
BePharma
Not Confirmed

Eftrenonacogum Alfa

Brand Name : Alprolix

Dosage Form : Solution For Injection

Dosage Strength : 250IU/5ml

Packaging :

Approval Date : 25/10/2016

Application Number : 66039

Regulatory Info : Allowed

Registration Country : Switzerland

blank

06

BePharma
Not Confirmed
arrow
arrow
BePharma
Not Confirmed

Eftrenonacogum Alfa

Brand Name : Alprolix

Dosage Form : Solution For Injection

Dosage Strength : 500IU/5ml

Packaging :

Approval Date : 25/10/2016

Application Number : 66039

Regulatory Info : Allowed

Registration Country : Switzerland

blank

07

BePharma
Not Confirmed
arrow
arrow
BePharma
Not Confirmed

Eftrenonacogum Alfa

Brand Name : Alprolix

Dosage Form : Solution For Injection

Dosage Strength : 1000IU/5ml

Packaging :

Approval Date : 25/10/2016

Application Number : 66039

Regulatory Info : Allowed

Registration Country : Switzerland

blank

08

BePharma
Not Confirmed
arrow
arrow
BePharma
Not Confirmed

Eftrenonacogum Alfa

Brand Name : Alprolix IE

Dosage Form : Solution For Injection

Dosage Strength : 2000IU/5ml

Packaging :

Approval Date : 25/10/2016

Application Number : 66039

Regulatory Info : Allowed

Registration Country : Switzerland

blank

09

BePharma
Not Confirmed
arrow
arrow
BePharma
Not Confirmed

Eftrenonacogum Alfa

Brand Name : Alprolix IE

Dosage Form : Injectable Solution

Dosage Strength : 3000IU/5ml

Packaging :

Approval Date : 25/10/2016

Application Number : 66039

Regulatory Info : Allowed

Registration Country : Switzerland

blank

10

BePharma
Not Confirmed
arrow
arrow
BePharma
Not Confirmed

Eftrenonacog alfa

Brand Name : Alprolix

Dosage Form : Solution For Injection

Dosage Strength : 1000IU

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

11

BePharma
Not Confirmed
arrow
arrow
BePharma
Not Confirmed

Eftrenonacog alfa

Brand Name : Alprolix

Dosage Form : Solution For Injection

Dosage Strength : 2000IU

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

12

BePharma
Not Confirmed
arrow
arrow
BePharma
Not Confirmed

Eftrenonacog alfa

Brand Name : Alprolix

Dosage Form : Solution For Injection

Dosage Strength : 250IU

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

13

BePharma
Not Confirmed
arrow
arrow
BePharma
Not Confirmed

Eftrenonacog alfa

Brand Name : Alprolix

Dosage Form : Solution For Injection

Dosage Strength : 3000IU

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

14

BePharma
Not Confirmed
arrow
arrow
BePharma
Not Confirmed

Eftrenonacog alfa

Brand Name : Alprolix

Dosage Form : Solution For Injection

Dosage Strength : 500IU

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

15

BePharma
Not Confirmed
arrow
arrow
BePharma
Not Confirmed

Eftrenonacog Alfa

Brand Name : Alprolix

Dosage Form : Powder And Solvent For Injectable Solution

Dosage Strength : 500IU

Packaging :

Approval Date : 23-06-2016

Application Number : 1161098002

Regulatory Info : Authorized

Registration Country : Spain

blank

16

BePharma
Not Confirmed
arrow
arrow
BePharma
Not Confirmed

Eftrenonacog Alfa

Brand Name : Alprolix

Dosage Form : Powder And Solvent For Injectable Solution

Dosage Strength : 1000IU

Packaging :

Approval Date : 23-06-2016

Application Number : 1161098003

Regulatory Info : Authorized

Registration Country : Spain

blank

17

BePharma
Not Confirmed
arrow
arrow
BePharma
Not Confirmed

Eftrenonacog Alfa

Brand Name : Alprolix

Dosage Form : Powder And Solvent For Injectable Solution

Dosage Strength : 250IU

Packaging :

Approval Date : 22-06-2016

Application Number : 1161098001

Regulatory Info : Authorized

Registration Country : Spain

blank

18

BePharma
Not Confirmed
arrow
arrow
BePharma
Not Confirmed

Eftrenonacog Alfa

Brand Name : Alprolix

Dosage Form : Powder And Solvent For Injectable Solution

Dosage Strength : 2000IU

Packaging :

Approval Date : 23-06-2016

Application Number : 1161098004

Regulatory Info : Authorized

Registration Country : Spain

blank

19

BePharma
Not Confirmed
arrow
arrow
BePharma
Not Confirmed

Eftrenonacog Alfa

Brand Name : Alprolix

Dosage Form : Powder And Solvent For Injectable Solution

Dosage Strength : 3000IU

Packaging :

Approval Date : 23-06-2016

Application Number : 1161098005

Regulatory Info : Authorized

Registration Country : Spain

blank

20

BePharma
Not Confirmed
arrow
arrow
BePharma
Not Confirmed

Eftrenonacog Alfa

Brand Name : Alprolix

Dosage Form : Solution For Injection

Dosage Strength : 250IE

Packaging :

Approval Date : 12-05-2016

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank